Financial results - ALIPHARM SRL

Financial Summary - Alipharm Srl
Unique identification code: 16572238
Registration number: J12/2470/2004
Nace: 4773
Sales - Ron
217.159
Net Profit - Ron
1.992
Employee
2
The most important financial indicators for the company Alipharm Srl - Unique Identification Number 16572238: sales in 2023 was 217.159 euro, registering a net profit of 1.992 euro and having an average number of 2 employees. Firma isi desfasoara activitatea in domeniul Comert cu amanuntul al produselor farmaceutice, in magazine specializate having the NACE code 4773.

Sales, Profit, Employees, Debts, Capitals, Financial Results - Alipharm Srl

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Sales - EUR 125.610 105.543 - - 157.814 106.972 78.086 182.228 207.870 217.159
Total Income - EUR 126.205 105.852 - - 165.616 106.972 78.924 182.356 207.872 217.161
Total Expenses - EUR 122.591 97.359 - - 135.533 98.464 77.526 163.166 153.619 212.454
Gross Profit/Loss - EUR 3.615 8.493 - - 30.083 8.508 1.398 19.190 54.253 4.707
Net Profit/Loss - EUR 2.867 6.394 - - 28.427 7.439 572 17.586 52.216 1.992
Employees 3 3 - - 3 3 2 3 3 2
Tabelul prezinta cei mai importanti indicatori ai firmei din Contul de Profit si Pierderi pentru ultimii 10 ani de activitate asa cum se regasesc la Ministerul de Finante. Datele ofera evolutia firmei in aceasta perioada privind cresterile si eventual descresterile inregistrate. In the last year of activity, the sales increased by 4.8%, from 207.870 euro in the year 2022, to 217.159 euro in 2023. The Net Profit decreased by -50.065 euro, from 52.216 euro in 2022, to 1.992 in the last year.

Check the financial reports for the company - Alipharm Srl

Rating financiar

Financial Rating -
Alipharm Srl

See the company's note based on the submitted financial data, relative to the industry of which it is a part.

Check Financial Rating
Limite de plata

Payment Limits -
Alipharm Srl

See the company's payment capacity for situations in which you conclude contracts with payment terms.

Check Payment Limits
Probabilitate de insolventa

Prob. of insolvency -
Alipharm Srl

It determines the risk of insolvency based on the submitted accounting balance.

Check Insolvency Probability
Rapoarte financiare

Financial Reports -
Alipharm Srl

Check all the financial reports of the company and know the risks in collaboration with it.

Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.

Debts, Equity, Inventories, Receivables, Accounts, Assets - Alipharm Srl - CUI 16572238

2014 2015 2016 2017 2018 2019 2020 2021 2022 2023
Fixed Assets 1.167 0 - - 0 0 0 0 0 0
Current Assets 35.617 49.750 - - 206.946 244.545 140.769 56.842 103.397 138.511
Inventories 7.112 18.834 - - 70.189 91.992 64.790 17.469 30.898 53.638
Receivables 11.771 24.139 - - 94.618 100.503 32.554 22.194 38.198 57.162
Cash 16.734 6.777 - - 42.139 52.050 43.425 17.179 34.301 27.711
Shareholders Funds -8.020 -1.692 - - 74.507 78.901 82.392 18.687 70.961 78.856
Social Capital 45 45 - - 43 42 41 40 41 81
Debts 44.804 51.443 - - 132.439 165.644 58.377 38.155 32.436 59.656
Income in Advance 0 0 - - 0 0 0 0 0 0
Exchange rate - RON 4.9465 4.9315 4.9468 4.8371 4.7454 4.6535 4.5681 4.4908 4.445 4.4821
Main CAEN "4773 - 4773"
CAEN Financial Year 4773
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of 138.511 euro in 2023 which includes Inventories of 53.638 euro, Receivables of 57.162 euro and cash availability of 27.711 euro.
The company's Equity was valued at 78.856 euro, while total Liabilities amounted to 59.656 euro. Equity increased by 8.110 euro, from 70.961 euro in 2022, to 78.856 in 2023.

Activate the Financial Reports subscription with unlimited access and check the evolution and current financial situation of any company.

Subscriptions Financial Reports

You can check the financial situation of the companies in relation to the industry of which it is a part, credit limits and the risk of insolvency and suspension of accounts.

Subscription cost is per user. You can pay simultaneously up to 10 users.
RisCo Subscriptions offer the greatest flexibility in choosing the best services according to the needs of each user. These are structured into categories based on the type of service desired, as well as on different service contract periods: monthly, semi-annually, and annually. Check out the subscription offer for the best choices!

Reviews - Alipharm Srl

Comments - Alipharm Srl

Similar services useful for checking companies and business development.

Contacts Firms

Get the contact details for any company and get in touch with it.

Sectoral Studies

Knows the market and develops its own development strategies according to sectorial data.

Company Lists

Create lists of companies for your sales activity according to your own criteria.

Import - Export

Find importers and exporters according to the type of activity and the countries in which they carry it out.

Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.